3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Surgery Strategies for Gastric Cancer With Liver Metastasis

      review-article
      , , *
      Frontiers in Oncology
      Frontiers Media S.A.
      gastric cancer, liver metastasis, surgery, strategy, R0 resection

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Gastric cancer with liver metastasis is defined as advanced gastric cancer and remains one of the deadliest diseases with poor prognosis. Approximately 4–14% of patients with gastric cancers presented with liver metastases at the initial diagnosis. Owing to its incurability, first-line treatment for gastric cancer with liver metastases is systematic chemotherapy, whereas surgery is usually performed to alleviate severe gastrointestinal symptoms. However, continuously emerging retrospective studies confirmed the role of surgery in gastric cancer with liver metastases and showed significantly improved survival rate in patients assigned to a group of surgery with or without chemotherapy. Therefore, more and more convincing data that resulted from prospective randomized clinical trials is in need to clarify the surgery strategies in patients with gastric cancer with liver metastasis.

          Related collections

          Most cited references78

          • Record: found
          • Abstract: found
          • Article: not found

          Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.

          Chemotherapy is the standard of care for incurable advanced gastric cancer. Whether the addition of gastrectomy to chemotherapy improves survival for patients with advanced gastric cancer with a single non-curable factor remains controversial. We aimed to investigate the superiority of gastrectomy followed by chemotherapy versus chemotherapy alone with respect to overall survival in these patients.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.

            The safety and efficacy of radical laparoscopic distal gastrectomy (LG) with D2 lymphadenectomy for the treatment of advanced gastric cancer (AGC) remain controversial. We conducted a randomized controlled trial to compare laparoscopic and conventional open distal gastrectomy with D2 lymph node dissections for AGC.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer.

              We evaluated the efficacy and safety of S-1 plus oxaliplatin (SOX) as an alternative to cisplatin plus S-1 (CS) in first-line chemotherapy for advanced gastric cancer (AGC).
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                06 December 2019
                2019
                : 9
                : 1353
                Affiliations
                Department of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University , Shanghai, China
                Author notes

                Edited by: Lin Chen, PLA General Hospital, China

                Reviewed by: Yoshiharu Sakai, Kyoto University, Japan; Song Wu, First Affiliated Hospital of Sun Yat-sen University, China

                *Correspondence: Chen Huang richard-hc@ 123456hotmail.com

                This article was submitted to Surgical Oncology, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2019.01353
                6915096
                31921626
                4d150f95-fba6-4638-bbe0-d8d642971e16
                Copyright © 2019 Luo, Rong and Huang.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 11 March 2019
                : 18 November 2019
                Page count
                Figures: 1, Tables: 2, Equations: 0, References: 92, Pages: 10, Words: 8280
                Funding
                Funded by: National Natural Science Foundation of China 10.13039/501100001809
                Categories
                Oncology
                Review

                Oncology & Radiotherapy
                gastric cancer,liver metastasis,surgery,strategy,r0 resection
                Oncology & Radiotherapy
                gastric cancer, liver metastasis, surgery, strategy, r0 resection

                Comments

                Comment on this article